-
What is the U.S. market status for two forms of birth control, the single-rod contraceptive implant and the contraceptive sponge? Answers to these questions are provided by Marcia Diljak, spokeswoman for West Orange, NJ-based Organon, and Gene Detroyer, president and chief executive officer of Allendale (NJ) Pharmaceuticals.
-
Need to brush up on your knowledge of current treatment practices when it comes to sexually transmitted diseases (STDs)? The Centers for Disease Control and Preventions (CDCs) Division of Sexually Transmitted Diseases is offering new on-line STD education modules.
-
Circle June 12-15, 2005, on the calendar to attend the 2005 National HIV Prevention Conference in Atlanta.
-
As you tell the patient in front of you that she has a positive test for chlamydia, you explain the importance of having her boyfriend treated. You encourage her to have the boyfriend come in for care, but what are the odds that you will see him?
-
Clinical trials for a male contraceptive that is a combination of progesterone and testosterone are expected to begin this year.
-
I have been a subscriber to Contraceptive Technology Update for many years and rarely take issue with the content. I must, however, register my total surprise and dismay at your 25 Events to Know in Reproductive Health that appeared in the January 2005 issue.
-
Its time to update your counseling on the injectable contraceptive depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer; New York City). The Food and Drug Administration (FDA) has added a black box warning to the drugs labeling to highlight that prolonged use may result in the loss of bone mineral density (BMD).
-
The first male contraceptives to make it to the market likely will be hormonal-based birth control, similar to what has worked well for female contraceptives for the past four decades. However, there are serious difficulties with hormonal contraceptives for men, so the possibilities that are beginning to excite researchers working in the contraceptive field are the nonhormonal methods.
-
A spray-on birth control method for women recently has entered a Phase I clinical trial in which six women in Sydney, Australia, are using the new product as part of a study to determine whether the transdermal contraceptive can be used in spray formulation effectively.
-
African American women are far more likely to be infected with HIV than are white women and Hispanic women, a problem that has been growing, according to recent reports by the Centers for Disease Control and Prevention (CDC).
